Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$AUPH Q3 '25 Earnings Results & Recap Aurinia Pharmaceuticals reported Q3 2025 EPS of $0.23, exceeding the estimate of $0.16, and revenue of $73.5M, surpassing the estimate of $67.7M; the company raised its 2025 Lupkynis sales guidance to $265M-$270M.
2

Since Post

Full Details

Advertisement|Remove ads.